| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/10/2002 | WO2002002819A1 Method of screening for chemotherapeutic treatments for cancer |
| 01/10/2002 | WO2002002818A1 Apparatus and method for preserving the uniqueness and identity of an individual |
| 01/10/2002 | WO2002002817A2 Multipartite high-affinity nucleic acid probes |
| 01/10/2002 | WO2002002815A1 Method of detecting nucleotide polymorphism |
| 01/10/2002 | WO2002002814A1 Highly sensitive method of detecting nucleic acid |
| 01/10/2002 | WO2002002813A2 Sequencing method |
| 01/10/2002 | WO2002002812A2 Method for determining the susceptibility to stoke by analysing the ins gene |
| 01/10/2002 | WO2002002811A2 Method for controlling the microbiological quality of an aqueous medium and kit therefor |
| 01/10/2002 | WO2002002810A2 Method for qualitative and/or quantitative detecting of molecular interactions on probe arrays |
| 01/10/2002 | WO2002002809A2 Diagnosis of behavioural disorders, neurological disorders and cancer |
| 01/10/2002 | WO2002002808A2 Method and nucleic acids for the analysis of astrocytomas |
| 01/10/2002 | WO2002002807A2 Diagnosis of diseases associated with cell signalling |
| 01/10/2002 | WO2002002806A2 Method and nucleic acids for analysing the methylation of genes implicated in pharmacogenomics |
| 01/10/2002 | WO2002002805A2 Method for identification, separation and quantitative measurement of nucleic acid fragments |
| 01/10/2002 | WO2002002803A2 Method for formulating molecular probes |
| 01/10/2002 | WO2002002802A1 Method of measuring total homocysteine |
| 01/10/2002 | WO2002002800A1 Micro-organisms with glycosylation modulating action of intestinal cell surface |
| 01/10/2002 | WO2002002799A1 Characterizing a brain tumor |
| 01/10/2002 | WO2002002797A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 01/10/2002 | WO2002002796A2 Disposable electrochemical bio-sensor for the quantitative determination of analyte concentrations in fluids |
| 01/10/2002 | WO2002002795A2 Multiplex sequencing method |
| 01/10/2002 | WO2002002792A1 Signal amplification with lollipop probes |
| 01/10/2002 | WO2002002784A1 Regulated gene expression in yeast and methods of use |
| 01/10/2002 | WO2002002780A2 Human serine-threonine kinase |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002769A1 A novel app mutation associated with an unusual alzheimer's disease pathology |
| 01/10/2002 | WO2002002766A2 Natural promoters for gene expression and metabolic monitoring in bacillus species |
| 01/10/2002 | WO2002002763A2 Recombinant staphylococcus aureus peptide deformylase |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002756A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | WO2002002749A1 Transformed yeast for constructing combinatorial protein library |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002741A2 Methods for genetic interpretation and prediction of phenotype |
| 01/10/2002 | WO2002002740A2 Methods and compositions for determining gene function |
| 01/10/2002 | WO2002002738A2 Host cells containing multiple integrating vectors |
| 01/10/2002 | WO2002002736A1 Reaction vessel, reaction device and temperature control method for reaction liquid |
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002627A2 Interferon-like protein zcyto21 |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002624A2 B7-like molecules and uses thereof |
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002609A1 Inhibitory pas domain protein (ipas) and screening methods related to angiogenesis and tumor progression |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002586A1 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 01/10/2002 | WO2002002584A1 Base analogues |
| 01/10/2002 | WO2002002580A2 Haplotypes of the etfb gene |
| 01/10/2002 | WO2002002579A2 Haplotypes of the eno3 gene |
| 01/10/2002 | WO2002002570A1 Chromogenic compound |
| 01/10/2002 | WO2002002227A2 Devices and methods for carrying out chemical reactions using photogenerated reagents |
| 01/10/2002 | WO2002002225A2 Single molecule sequencing method |
| 01/10/2002 | WO2002002138A1 Treating endotoxemia and related disorders with probiotics |
| 01/10/2002 | WO2002002055A2 Antifungal compounds and methods of use |
| 01/10/2002 | WO2002002054A2 Methods and compositions for the diagnosis of schizophrenia |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2002002000A2 Methods of screening for alzheimer's disease |
| 01/10/2002 | WO2002001953A1 Methods to screen for antibiotic agents and their use in treatment of opportunistic infections |
| 01/10/2002 | WO2002001950A2 Transgenic mice containing targeted gene disruptions |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001075084A3 Coffee mannanase |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001055307A3 Nucleic acids, proteins, and antibodies |
| 01/10/2002 | WO2001051651A3 High expression and production of high-specific activity recombinant s-adenosyl homocysteinase (sahh) and improved assays for s-adenosylmethionine (sam) |
| 01/10/2002 | WO2001049708A3 Peptide ligands that mimic sensor kinases and inhibit response regulators |
| 01/10/2002 | WO2001048145A3 High affinity tcr proteins and methods |
| 01/10/2002 | WO2001046398A3 Aspartyl proteases |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045495A3 Potassium channel stress-related proteins and methods of use in plants |
| 01/10/2002 | WO2001044455A3 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 01/10/2002 | WO2001043691A3 Fragments and antagonists of heat shock protein 60 |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001042422A3 Acyl glucosaminyl inositol amidase family and methods of use |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001038560A3 Active enzyme detection using immobilized enzyme inhibitors |
| 01/10/2002 | WO2001036685A3 Differential gene expression in cancer |
| 01/10/2002 | WO2001036474A3 Srik a novel cell cycle protein associated with rip3 |
| 01/10/2002 | WO2001036472A3 Compositions and methods for regulating tumor-associated antigen expression |
| 01/10/2002 | WO2001034835A3 Method for the production of biopolymers with modified properties |
| 01/10/2002 | WO2001034302A3 Biochannel assay for hybridization with biomaterial |
| 01/10/2002 | WO2001029254A3 Identification of bpesc1, a gene disrupted by a balanced chromosomal translocation t(3;4) (q23;p15.2) in a patient with bpes |
| 01/10/2002 | WO2001027327A3 Method and apparatus for performing large numbers of reactions using array assembly |
| 01/10/2002 | WO2001027312A3 Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene |
| 01/10/2002 | WO2001025410A3 DIAGNOSTIC PROBES AND THERAPEUTICS TARGETING uPA AND uPAR |
| 01/10/2002 | WO2001018050A3 T2r taste receptor family |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001002600A3 Detection of analytes using attenuated enzymes |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000079274A3 Methods for assaying subcellular conditions using energy transfer |
| 01/10/2002 | WO2000063440A3 Diagnostic standards for virus detection and quantification |
| 01/10/2002 | WO2000061817A9 Multiplex amplification and separation of nucleic acid sequences on a bioelectronic microchip using asymmetric structures |
| 01/10/2002 | WO2000060119A3 Methods for detecting cancer cells |